Nachrichten zur Bristol-Myers Squibb Co. Aktie

Why Is Everyone Talking About Bristol Myers Squibb Stock?

Heres why this cheap blue-chip pharma stock is a solid buy for dividend, value, and growth investors alike....…

Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Bristol Myers Squibb (BMY) closed at $58.38, marking a +1.42% move from the previous day....…

Bristol Myers Squibb Offers Growth With A Safe Dividend

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb (BMY) is a Top Dividend Stock Right Now: Should You Buy? (Revised)

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Kitov Pharma +49% on collaboration with Bristol Myers for lung cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

CytomX Therapeutics Announces Preclinical Data from Anti-CTLA-4 Probody Therapeutic Programs Presented by Partner Bristol Myers Squibb at AACR Annual Meeting

Preclinical Data Supports Expanded Therapeutic Index and Provides Rationale for Ongoing Clinical Studies Preclinical Data Supports Expanded Therapeutic Index and…

Better Buy: Biogen vs. Bristol Myers Squibb

Neither drugmaker has been a winner this year. But one appears to be a pretty safe bet to win in…

Could Bristol Myers Squibb Be a Millionaire-Maker Stock?

This healthcare stock could be a gamechanger for long-term investors who buy in today....…

The Zacks Analyst Blog Highlights: Eli Lilly & Company, AstraZeneca, AbbVie and Bristol-Myers Squibb

The Zacks Analyst Blog Highlights: Eli Lilly & Company, AstraZeneca, AbbVie and Bristol-Myers Squibb...…

Bristol-Myers Squibb (BMY) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

The Zacks Analyst Blog Highlights: Netflix, Bristol-Myers Squibb, NextEra Energy, Goldman Sachs and Illumina

The Zacks Analyst Blog Highlights: Netflix, Bristol-Myers Squibb, NextEra Energy, Goldman Sachs and Illumina...…

Top Research Reports for Netflix, Bristol-Myers & NextEra

Top Research Reports for Netflix, Bristol-Myers & NextEra...…

Bristol-Myers Squibb (BMY) Stock Moves -0.19%: What You Should Know

Bristol-Myers Squibb (BMY) closed at $56.95 in the latest trading session, marking a -0.19% move from the prior day....…

Zacks.com featured highlights include: Big Lots, Dollar General, Kroger and Bristol-Myers

Zacks.com featured highlights include: Big Lots, Dollar General, Kroger and Bristol-Myers...…

Bristol Myers initiates registered exchange offers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Signs That Bristol Myers Squibb Can Finally Break Cycle Of Under-Performance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

3 Reasons Growth Investors Will Love Bristol-Myers (BMY)

Bristol-Myers (BMY) is well positioned to outperform the market, as it exhibits above-average growth in financials....…

Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 41st Annual Global Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is Bristol-Myers Squibb (BMY) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

Bristol Myers Squibb declares $0.45 dividend

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Gets FDA Nod for Label Expansion of Opdivo

Bristol-Myers (BMY) gets FDA nod for Opdivo for the treatment of esophageal squamous cell carcinoma....…

Clovis Completes Enrollment in Late-Stage Ovarian Cancer Study

Clovis (CLVS) is developing Rubraca as monotherapy as well as in combination with Bristol-Myers Opdivo as first-line maintenance treatment for…

Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know

Bristol-Myers Squibb (BMY) closed at $60.16 in the latest trading session, marking a -1.26% move from the prior day....…

Bristol Myers Squibb, UbiVac to assess combination immunotherapy for advanced triple-negative breast cancer

The partnership will assess the safety, tolerability, and preliminary efficacy of UbiVacs investigational product DRibble Platform Vaccine 001(DPV-001) in combination…

Bristol Myers teams up with UbiVac in study of triplet therapy for breast cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers (BMY) Up 0.5% Since Last Earnings Report: Can It Continue?

Bristol-Myers (BMY) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Bristol-Myers Squibb (BMY) Gains As Market Dips: What You Should Know

In the latest trading session, Bristol-Myers Squibb (BMY) closed at $60.89, marking a +1.13% move from the previous day....…

Jounce regains rights to cancer candidate from Bristol Myers Squibb

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Better Buy: Bristol Myers Squibb vs. Gilead Sciences

Which of these household names is the better buy?...…

Why Bristol-Myers Squibb (BMY) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Bristol Myers Squibb announces positive topline results from True North trial evaluating Zeposia in ulcerative colitis

True North met both primary endpoints, demonstrating highly statistically significant (p-value < 0.0001) results for induction of clinical remission at…

Zacks.com featured highlights include: Keurig Dr Pepper, Bristol-Myers Squib, Vistra Energy, IHS Markit and Campbell Soup

Zacks.com featured highlights include: Keurig Dr Pepper, Bristol-Myers Squib, Vistra Energy, IHS Markit and Campbell Soup...…

Bristol-Myers Squibb Colitis Drug Meets Late-Stage Goals

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibbs stock rises on Zeposia trial findings, launch in the U.S.

Shares of Bristol-Myers Squibb Inc. gained 1.2% in premarket trading on Tuesday after the drugmaker said Zeposia met both…

The Zacks Analyst Blog Highlights: Merck, Glaxo, Roche, Sanofi and Bristol-Myers

The Zacks Analyst Blog Highlights: Merck, Glaxo, Roche, Sanofi and Bristol-Myers...…

Bristol Myers launches MS med Zeposia in U.S.

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know

Bristol-Myers Squibb (BMY) closed at $59.72 in the latest trading session, marking a -0.15% move from the prior day....…

Is Bristol-Myers (BMY) a Solid Growth Stock? 3 Reasons to Think " Yes "

Bristol-Myers (BMY) possesses solid growth attributes, which could help it handily outperform the market....…

Bristol-Myers (BMY) Wins EC Approval for MS Drug Zeposia

Bristol-Myers (BMY) gets EC nod for Zeposia for the treatment of adult patients with relapsing remitting multiple sclerosis....…

Bristol Myers Squibb receives EC approval for Zeposia in adults with RRMS with active disease

With the EC marketing authorization, Zeposia, an oral medication taken once daily, becomes the only approved sphingosine-1-phosphate (S1P) receptor modulator…

Should Value Investors Buy Bristol-Myers Squibb (BMY) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

EMA accepts Bristol Myers applications for blood cancer treatments

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

The Zacks Analyst Blog Highlights: Facebook, Johnson & Johnson, Fidelity National Information Services, Alibaba and Bristol-Myers Squibb

The Zacks Analyst Blog Highlights: Facebook, Johnson & Johnson, Fidelity National Information Services, Alibaba and Bristol-Myers Squibb...…

Buy Bristol-Myers Squibb For 25% Gains-

Bristol-Myers Squibbs stock (NYSE: BMY) has significantly outperformed the broader markets as well as some of its peers over the…

Zacks.com featured highlights include: Taiwan Semiconductor Manufacturing Company, Dollar General, Kroger, Bristol-Myers Squibb and NIC

Zacks.com featured highlights include: Taiwan Semiconductor Manufacturing Company, Dollar General, Kroger, Bristol-Myers Squibb and NIC...…